You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金城醫藥(300233.SZ)及子公司捐贈450萬元支持抗擊新型冠狀病毒肺炎疫情
格隆匯 02-04 18:40

格隆匯2月4日丨金城醫藥(300233.SZ)公佈,為應對近期新型冠狀病毒肺炎疫情,援助和支持疫情防控工作,承擔社會責任,公司及下屬子公司捐贈現金、產品及各類防護物資約450萬元,以支持此次抗擊疫情工作。其中:公司及各子公司捐贈現金130萬元;酒精、消毒液以及口罩等防護物資約20萬元;子公司北京金城泰爾製藥有限公司捐贈藥品匹多莫德分散片價值約40萬元,主要用於慢性或反覆發作的呼吸道感染和尿路感染的輔助治療;子公司廣東金城金素製藥有限公司捐贈注射用亞胺培南西司他丁價值約260萬元,主要用於多種病原體所致和需氧/厭氧菌引起的混合感染以及在病原菌未確定前的早期治療。亞胺培南西司他丁為廣東省衞生健康委員會關於提供新型冠狀病毒感染的肺炎防控物資參考清單目錄品種。

公司此次對外捐贈是為了支持抗擊新型冠狀病毒肺炎疫情,是公司積極承擔社會責任的體現。此次對外捐贈資金及產品均來源於公司自有資金、產品及獨家代理銷售產品。此次對外捐贈對公司當期及未來經營業績不構成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account